{"id":23,"date":"2016-01-04T14:12:07","date_gmt":"2016-01-04T14:12:07","guid":{"rendered":"http:\/\/mind-interdisciplinary-medicine.com\/?page_id=23"},"modified":"2019-05-20T17:01:44","modified_gmt":"2019-05-20T17:01:44","slug":"results","status":"publish","type":"page","link":"https:\/\/www.proscholar.org\/finasteride\/results","title":{"rendered":"Results"},"content":{"rendered":"
<\/h5>\n

 <\/p>\n

Dissemination of the project results<\/u><\/strong><\/h3>\n

 <\/p>\n

A. Articles related to the study:<\/h4>\n

 <\/p>\n

Expert Opinion on Drug Safety<\/span><\/em><\/p>\n

    \n
  1. Motofei IG, Rowland DL, Tampa M, Sarbu MI, Mitran MI, Mitran CI, Stoian AP, Diaconu CC, Paunica S, Georgescu SR. Finasteride and androgenic alopecia; from therapeutic options to medical implications. J Dermatolog Treat. 2019 Mar 21:1-7. DOI: 10.1080\/09546634.2019.1595507. PMID: 30897009<\/li>\n
  2. Motofei IG, Rowland DL, Baconi DL, Tampa M, S\u00e2rbu MI, P\u0103unic\u0103 S,\u00a0Constantin VD, B\u0103l\u0103l\u0103u C, P\u0103unic\u0103 I, Georgescu SR.\u00a0Androgenetic alopecia; drug safety and therapeutic strategies.\u00a0Expert Opinion on Drug Safety 2018;\u00a017(4): 407-412. PMID:\u00a029363345,\u00a0DOI: 10.1080\/14740338.2018.1430765\n<\/ol>\n

    Farmacia<\/em><\/span><\/p>\n

      \n
    1. Motofei IG, Rowland DL, Baconi DL, Georgescu SR, Paunic\u0103 S, Constantin VD, B\u0103l\u0103l\u0103u D, Paunic\u0103 I, B\u0103l\u0103l\u0103u C, Baston C, Sinescu I. Therapeutic considerations related to Finasteride administration in male androgenic alopecia and benign prostatic hyperplasia. Farmacia\u00a02017; 65(5): 660-666.<\/li>\n<\/ol>\n

      Skin Pharmacology and Physiology, 2017<\/em><\/span><\/p>\n

        \n
      1. Motofei IG, Rowland DL, Georgescu SR, Tampa M, P\u0103unic\u0103 S, Constantin VD, Balalau C, Manea M, Baleanu BC, Sinescu I. Post-Finasteride Adverse Effects in Male Androgenic Alopecia: A Case Report of Vitiligo. Skin Pharmacol Physiol. 2017, 30(1): 42-45. doi: 10.1159\/000455972.<\/li>\n<\/ol>\n

        Clinical Drug Investigation, 2017<\/em><\/span><\/p>\n

          \n
        1. Motofei IG, Rowland DL, Manea M, Georgescu SR, Paunica I, Sinescu I. Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind\/Brain. Clin Drug Investig. 2017. DOI 10.1007\/s40261-017-0501-8<\/li>\n<\/ol>\n

          Journal of Dermatological Treatment, 2016<\/em><\/span><\/p>\n

            \n
          1. Motofei IG, Rowland DL, Georgescu SR, Tampa M, Baconi D, Stefanescu E, Baleanu BC, Balalau C, Constantin V, Paunica S. Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain. J Dermatolog Treat. 2016; 4: 1-3. PMID: 27046152<\/li>\n<\/ol>\n

            Experimental Dermatology, 2016<\/em><\/span><\/p>\n

              \n
            1. Motofei IG, Rowland DL, Georgescu SR, Mircea T, Baleanu BC, Paunica S. Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia? Exp Dermatol. 2016; 25(7): 557- 8. doi: 10.1111\/exd.13003. PMID: 26990657<\/li>\n<\/ol>\n

              Journal of Mind and Medical Sciences: 2018, 2017, 2016, 2015<\/em><\/span><\/p>\n

                \n
              1. Rowland DL, Motofei IG, P\u0103unic\u0103 I, Banu P, Nistor MF, P\u0103unic\u0103 S, Constantin VD. Androgenic alopecia; the risk\u2013benefit ratio of Finasteride. J Mind Med Sci. 2018; 5(1): 1-6. DOI: 10.22543\/7674.51.P16<\/li>\n
              2. Motofei IG, Rowland DL. P\u0103unic\u0103 I, T\u0103n\u0103sescu OC, Banu P, P\u0103unic\u0103 S. Finasteride as a model for personalized medicine. J Mind Med Sci. 2017; 4(2): 125-131.<\/li>\n
              3. David L. Rowland, Ion G. Motofei, Florian Popa, Vlad D. Constantin, Adriana Vasilache, Ioana P\u0103unic\u0103, Cristian B\u0103l\u0103l\u0103u, Georgeta P. P\u0103unic\u0103, Petrisor Banu, and Stana P\u0103unic\u0103. The postfinasteride syndrome; an overview. J Mind Med Sci. 2016; 3(2): 99-107. ISSN: 2392-7674<\/li>\n
              4. Paunica S, Giurgiu M, Vasilache A, Paunica I, Motofei I, Vasilache A, Dumitriu HT, Dumitriu AS. Finasteride adverse effects and post-finasteride syndrome; implications for dentists. J Mind Med Sci. 2016; 3(1): 71- 79. ISSN: 2392-7674<\/li>\n
              5. Manea M, Paunica I, Puiu GM, Manea CM. Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia. J Mind Med Sci. 2015; 2(2): 142-149. ISSN: 2392-7674<\/li>\n<\/ol>\n

                Journal of Investigative Dermatology (abstracts): 2016, 2015, 2014<\/span><\/em><\/p>\n

                  \n
                1. Rowland DL, Motofei IG, Georgescu SR, Tampa M, Sinescu I. Hand preference and sexual orientation as useful elements to predict finasteride side effects in male androgenic alopecia. 46th ESDR Congress, Journal of Investigative Dermatology (abstract): 136(9): S195, 2016; DOI: 10.1016\/j.jid.2016.06.218<\/li>\n
                2. Georgescu SR, Paunica S, Tampa M, Paunica I, Baleanu CB, Motofei IG. Uncommon Finasteride side effects in male androgenic alopecia. 46th ESDR Congress, Journal of Investigative Dermatology (abstract): 136(9): S195, 2016; DOI: 10.1016\/j.jid.2016.06.219<\/li>\n
                3. Motofei IG, Rowland DL, Georgescu SR, Tampa M, Constantin VD, Paunica S, Baleanu CB, Sinescu I. Dutasteride for men with androgenic alopecia unresponsive to Finasteride. 46th ESDR Congress, Journal of Investigative Dermatology (abstract): 136(9): S195, 2016; DOI: 10.1016\/j.jid.2016.06.217<\/li>\n
                4. Motofei IG, Rowland DL, Georgescu SR, Tampa M, Paunica S, Baston C, Gingu C, Sinescu I. The post-finasteride syndrome after distinct doses\/ affections; ESDR-Congress 2015, Journal of Investigative Dermatology (abstract); 135, S40, 2015. ISSN: 0022-202X, Impact Factor 2014\/ IF: 7,216<\/li>\n
                5. Georgescu SR, Tampa M, Paunica S, Balalau C, Constantin VD, Paunica PG, Motofei IG. Distribution of post-finasteride syndrome in men with androgenic alopecia. ESDR-Congress 2015, Journal of Investigative Dermatology (abstract); 135, S40, 2015. ISSN: 0022-202X, Impact Factor 2014\/ IF: 7,216<\/li>\n
                6. Paunica S, Dumitriu A, Georgescu SR, Paunica I, Sarbu M, Tampa M, Motofei IG. Gingival hypertrophy to finasteride in male androgenic alopecia; ESDR-Congress 2015, Journal of Investigative Dermatology (abstract); 135, S40, 2015. ISSN: 0022-202X, Impact Factor 2014\/ IF: 7,216<\/li>\n
                7. Motofei IG, Rowland DL, Paunica S, Tampa M, Georgescu SR. Lateralized sexual side effects of Finasteride in subjects with androgenic alopecia. ESDR-Congress 2014, Journal of Investigative Dermatology (abstract); 134(2): S69, 2014 ISSN: 0022-202X, Impact Factor 2014\/ IF: 7,216<\/li>\n<\/ol>\n

                  European Academy of Dermatology and Venereology Congresses: 2016, 2015, 2014<\/span><\/em><\/p>\n

                    \n
                  1. Motofei IG, Baleanu CB, Georgescu SR, Tampa M, Baston C, Gingu V, Sinescu I. Dutasteride as possible alternative therapy for men with androgenetic alopecia unresponsive to Finasteride. 25th<\/sup> EADV\/ European Academy of Dermatology and Venereology Congress, Vienna, Austria, 28 Sept- 02 Oct., 2016, ISBN: 978-88-906829-9-5.<\/li>\n
                  2. Georgescu SR, Tampa M, P\u0103unic\u0103 S, Constantin V, B\u0103l\u0103l\u0103u C, Baleanu CB, Motofei IG. Post-Finasteride syndrome in male androgenic alopecia: clinical manifestations and hormonal imbalances. 25th<\/sup> EADV\/ European Academy of Dermatology and Venereology Congress, Vienna, Austria, 28 Sept- 02 Oct., 2016, ISBN: 978-88-906829-9-5.<\/li>\n
                  3. P\u0103unic\u0103 S, Dumitriu AS, Georgescu SR, Tampa M, P\u0103unic\u0103 I, Baleanu CB, Motofei IG. Finasteride and Dutasteride in male androgenic alopecia; comparable adverse effects at oral cavity. 25th<\/sup> EADV\/ European Academy of Dermatology and Venereology Congress, Vienna, Austria, 28 Sept- 02 Oct., 2016, ISBN: 978-88-906829-9-5.<\/li>\n
                  4. Motofei IG, Baleanu B, Paunica S, Constantin VD, Balalau C, Sarbu MI, Limbau A, Benea V, Tampa M, Georgescu SR. \u201dPost-Finasteride\u201d syndrome in male androgenic alopecia: variation of testosterone, progesterone and estradiol metabolites. 13th EADV\/ European Academy of Dermatology and Venereology Spring Symposium, Megaron Center, Athens, Greece, 19- 22 May 2016, ISBN: 978-88-906 829-7-1.<\/li>\n
                  5. Motofei IG, Baleanu B, Georgescu SR, Tampa M, Baston C, Gingu C, Sinescu I. Finasteride and Dutasteride side effects in male androgenetic alopecia; still insufficient data to support a post-dutasteride syndrome. 13th EADV\/ European Academy of Dermatology and Venereology Spring Symposium, Megaron Center, Athens, Greece, 19- 22 May 2016, ISBN: 978-88-906 829-7-1.<\/li>\n
                  6. Georgescu SR, Tampa M, Sarbu MI, Limbau A, Benea V, Paunica I, Baleanu B, Motofei IG. Finasteride and post-Finasteride adverse effects; similarities and delineations. 13th EADV\/ European Academy of Dermatology and Venereology Spring Symposium, Megaron Center, Athens, Greece, 19- 22 May 2016, ISBN: 978-88-906 829-7-1.<\/li>\n
                  7. Paunica S, Dumitriu A, Georgescu SR, Tampa M, Sarbu MI, Limbau A, Benea V, Baleanu B, Motofei IG. Finasteride in male androgenic alopecia; underestimated oral side effects. 13th EADV\/ European Academy of Dermatology and Venereology Spring Symposium, Megaron Center, Athens, Greece, 19- 22 May 2016, ISBN: 978-88-906 829-7-1.<\/li>\n
                  8. Motofei IG, Tampa M, P\u0103unic\u0103 S, B\u0103l\u0103l\u0103u C, Constantin D, Manea M, Ceban I, Limb\u0103u AM, Georgescu SR. Adverse effects of Finasteride and \u201dpost-Finasteride\u201d syndrome. 24TH EADV\/ European Academy of Dermatology and Venereology Congress, October 7- 11, 2015, Bella Center Copenhagen, Denmark, ISBN: 978-88-906829-5-7.<\/li>\n
                  9. Motofei IG, Tampa M, P\u0103unic\u0103 S, B\u0103l\u0103l\u0103u C, Constantin D, Ceban I, Limb\u0103u AM, Benea V, Georgescu SR. \u201dPost-Finasteride\u201d syndrome and variation of testosterone and progesterone metabolites. 24THEADV\/ European Academy of Dermatology and Venereology Congress, October 7- 11, 2015, Bella Center Copenhagen, Denmark, ISBN: 978-88-906829-5-7.<\/li>\n
                  10. Motofei IG, Rowland D, Tampa M, Benea V, Limbau A, Paunica S, Constantin V, Balalau C, Georgescu SR. Finasteride in male pattern hair loss; sexual side effects and variation of DHT plasmatic level. 12th EADV\/ European Academy of Dermatology and Venereology Spring Symposium, Valencia, Spain, 5- 8 March 2015, ISBN: 978-88-906 829-3-3.<\/li>\n
                  11. Motofei IG, Tampa M, Benea V, Rusu A., Sarbu I, Georgescu SR. Finasteride in male pattern hair loss; lateralization of sexual side effects. 23rd EADV\/ European Academy of Dermatology and Venereology Congress, Amsterdam RAI Convention Centre, 8- 12 October 2014, ISBN: 978-88-906829-1-9.<\/li>\n
                  12. Motofei IG, Georgescu SR, Tampa M, Baston C, Haineala B, Sinescu I. Similarities and differences between sexual side effects of Finasteride and Dutasteride in male androgenetic alopecia. 23rdEADV\/ European Academy of Dermatology and Venereology Congress, Amsterdam RAI Convention Centre, 8- 12 October 2014, ISBN: 978-88-906829-1-9.<\/li>\n<\/ol>\n

                    Romanian Congress of Dermatology with International Participation: 2016, 2015, 2014<\/em><\/span><\/p>\n

                      \n
                    1. Motofei IG, Tampa M, Manea M, P\u0103unic\u0103 I, Georgescu SR. Alopecia androgenic\u0103 \u0219i reac\u021biile adverse ale Finasteridei, \u00een timpul perioadei terapeutice \u0219i dup\u0103 oprirea administr\u0103rii. Congresul National de Dermatologie, Centrul Interna\u021bional de Conferin\u021be \u201eCasino Sinaia\u201d, 19\u201322 Octombrie, 2016.<\/li>\n
                    2. Georgescu SR, Tampa M, P\u0103unic\u0103 I, Motofei IG. Sindromul postfinasterid\u0103 la b\u0103rba\u021bii cu alopecie androgenic\u0103 \u0219i varia\u021bia plasmatic\u0103 a testosteronului, progesteronului \u0219i estradiolului. Congresul National de Dermatologie, Centrul Interna\u021bional de Conferin\u021be \u201eCasino Sinaia\u201d, 19\u201322 Octombrie, 2016.<\/li>\n
                    3. Motofei IG, P\u0103unic\u0103 S, Tampa M, Benea V, Limb\u0103u A, S\u00e2rbu I, P\u0103unic\u0103 I, Georgescu SR. Sindromul \u201dPost-Finasterid\u0103\u201d \u0219i varia\u021bia plasmatic\u0103 a hormonilor sexuali \u00een alopecia androgenic\u0103. 14TH National Congress of Dermatology with International Participation, October 21-24, 2015, Bucharest, Dermatovenerologie (Revista Societatii Romane de Dermatologie), 60: 107 (Supplement), ISSN: 1220-3734<\/li>\n
                    4. Motofei IG, Paunica S, Tampa M, Sarbu I, Ghenunche O, Danaila V, Georgescu SR. Lateralizarea reactiilor adverse sexuale ale Finasteridei in alopecia androgenetica. The 13th National Congress of Dermatology with International Participation, Dermatovenerologie (Revista Societatii Romane de Dermatologie); 59(P21): 101, 2014 ISSN: 1220-3734.<\/li>\n<\/ol>\n

                      Journal of Clinical Periodontology<\/em><\/span><\/p>\n

                        \n
                      1. Paunica S, Giurgiu MC, Popa S, Dumitriu HT, Motofei I, Dumitriu AS. Adverse effects at the level of marginal periodontium secondary to Finasteride administration. Journal of Clinical Periodontology 2018; 45(S19): 377. https:\/\/doi.org\/10.1111\/jcpe.38_12916<\/a> (9th Congress of the European Federation of Periodontology, EuroPerio 9, PC039, June 20-23, 2018, Amsterdam)<\/li>\n<\/ol>\n

                        UNAS Congress (http:\/\/www.unas.unas.ro)<\/em><\/span><\/p>\n

                          \n
                        1. P\u0103unic\u0103 S, Mali\u0163a C, Giurgiu M, Dumitriu HT, Dumitriu AS. Secondary possible effects of Finasteride administration at marginal periodontium. 19TH UNAS Congress, October 7- 10, 2015, Crystal Palace Ballrooms, Bucharest.<\/li>\n<\/ol>\n

                           <\/p>\n

                          B. Articles related to the project topic, published by members of the team during this study:<\/h4>\n
                            \n
                          1. Motofei IG, Rowland DL, Georgescu SR, Dimcevici P, Paunica S, Constantin V, B\u0103l\u0103l\u0103u C. A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness. BJU Int. 2013; 111(4): E 221- 6.<\/li>\n
                          2. Motofei IG, Rowland DL. The ventral-hypothalamic input route: a common neural network for abstract cognition and sexuality. BJU Int. 2014; 113(2): 296- 303.<\/li>\n
                          3. Motofei IG, Rowland DL, Popa F, Bratucu E, Straja D, Manea M, Georgescu SR, Paunica S, Bratucu M, Balalau C, Constantin VD. A Pilot Study on Tamoxifen Sexual Side Effects and Hand Preference in Male Breast Cancer. Arch Sex Behav. 2015; 44(6): 1589- 1594. ISSN: 0004-0002.<\/li>\n
                          4. Rowland DL, Neal CJ. Understanding men\u2019s attributions of why they ejaculate before desired: an internet study. J Sex Med. 2014; 11(10): 2554-61.<\/li>\n
                          5. Rowland DL, Motofei IG. The mind and sexuality: Introduction to a Psychophysiological Perspective,J Mind Med Sci. 2015; 2(1): 1-8.<\/li>\n
                          6. Motofei IG, Rowland DL. Solving the mind-body problem through two distinct concepts: internal-mental existence and internal mental reality. J Mind Med Sci. 2015; 2(2): 100- 112.<\/li>\n
                          7. B\u0103l\u0103l\u0103u C, Voiculescu S, Motofei IG, Sc\u0103unasu RV, Negrei C. Low dose Tamoxifen as treatment of benign breast proliferative lesions. Farmacia 2015; 63(3): 371- 375.<\/li>\n
                          8. Rowland DL. Commentary on: Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other than Premature Ejaculation: A Prospective, Observational Study. J Sex Med. 2015; 12(12): 2287-90.<\/li>\n
                          9. Rowland DL, Kolba TN. Understanding the effects of establishing various cutoff criteria in the definition of men with premature ejaculation. J Sex Med. 2015; 12(5): 1175-83.<\/li>\n
                          10. Rowland DL, Adamski BA, Neal CJ, Myers AL, Burnett AL. Self-efficacy as a relevant construct in understanding sexual response and dysfunction. J Sex Marital Ther. 2015; 41(1): 60-71.<\/li>\n
                          11. Motofei IG, Rowland DL. The mind body problem, part three: ascension of sexual function to cerebral level. J Mind Med Sci. 2016; 3(1): 1-12.<\/li>\n
                          12. Motofei IG, Rowland DL. Structural dichotomy of the mind; the role of sexual neuromodulators. J Mind Med Sci. 2016; 3(2): 131-140.<\/li>\n
                          13. Rowland DL, Kolba TN. Understanding Orgasmic Difficulty in Women. J Sex Med. 2016; 13(8): 1246-54.<\/li>\n
                          14. Rowland DL, Mikolajczyk LC, Pinkston DM, Reed HM, Lo DM. Attribution Patterns in Men Who Ejaculate Before They Desire: An Internet Survey. J Sex Marital Ther. 2016; 42(5): 462-73.<\/li>\n
                          15. Motofei IG, Rowland DL. Informational dichotomy of the mind; the role of sexual neuromodulators. J Mind Med Sci. 2017; 4(1): 19-23. doi: 10.22543\/7674.41.P1923<\/li>\n
                          16. Motofei IG, Rowland DL, P\u0103unic\u0103 I, T\u0103n\u0103sescu OC, Banu P, P\u0103unic\u0103 S. Finasteride as a model for personalized medicine. J Mind Med Sci. 2017; 4(2): 125-131. doi: 10.22543\/7674.42.P125131<\/li>\n
                          17. Motofei IG, Rowland Dl. The mind-body problem; three equations and one solution represented by immaterial-material data. J Mind Med Sci. 2018; 5(1): 59-69. DOI: 10.22543\/7674.51.P5969<\/li>\n
                          18. Rowland DL, Motofei IG, P\u0103unic\u0103 I, Banu P, Nistor MF, P\u0103unic\u0103 S, Constantin VD. Androgenic alopecia; the risk\u2013benefit ratio of Finasteride. J Mind Med Sci. 2018; 5(1): 1-6. DOI: 10.22543\/7674.51.P16<\/li>\n<\/ol>\n

                            Top<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

                              Dissemination of the project results   A. Articles related to the study:   Expert Opinion on Drug Safety Motofei IG, Rowland DL, Tampa M, Sarbu MI, Mitran MI, Mitran CI, Stoian AP, Diaconu CC, Paunica S, Georgescu SR. Finasteride and androgenic alopecia; from therapeutic options to medical implications. J Dermatolog Treat. 2019 Mar 21:1-7. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":30,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-23","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/pages\/23","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/comments?post=23"}],"version-history":[{"count":171,"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/pages\/23\/revisions"}],"predecessor-version":[{"id":827,"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/pages\/23\/revisions\/827"}],"wp:attachment":[{"href":"https:\/\/www.proscholar.org\/finasteride\/wp-json\/wp\/v2\/media?parent=23"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}